Atea Pharmaceuticals, Inc.
AVIR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593899
No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Atea Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 126
- 0 vs. Q2 2022
- Shares held
- 57.4M
- −64.0K (−0.1%) vs. Q2 2022
- Total value
- $326.8M
- −$81.9M (−20.0%) vs. Q2 2022
- New holders
- 15
- 50 more added
- Sold out
- 15
- 34 more reduced
2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 124 | $276.4M |
| Q1 2026 | 127 | $322.8M |
| Q4 2025 | 111 | $203.5M |
| Q3 2025 | 115 | $154.2M |
| Q2 2025 | 107 | $189.7M |
| Q1 2025 | 104 | $158.3M |
| Q4 2024 | 107 | $188.7M |
| Q3 2024 | 108 | $194.0M |
| Q2 2024 | 105 | $187.7M |
| Q1 2024 | 113 | $219.6M |
| Q4 2023 | 108 | $168.3M |
| Q3 2023 | 119 | $170.6M |
| Q2 2023 | 133 | $213.3M |
| Q1 2023 | 131 | $190.2M |
| Q4 2022 | 131 | $278.1M |
| Q3 2022 | 126 | $326.8M |
| Q2 2022 | 128 | $408.7M |
| Q1 2022 | 127 | $396.6M |
| Q4 2021 | 143 | $479.2M |
| Q3 2021 | 142 | $1.99B |
| Q2 2021 | 104 | $1.27B |
| Q1 2021 | 82 | $3.20B |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Atea Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 4,536 | $26.0K | 0.00% | +2,507+123.6% | Added |
| Russell Investments Group, Ltd. | 4,508 | $25.0K | 0.00% | +905+25.1% | Added |
| Denali Advisors LLC | 4,400 | $25.0K | 0.01% | +4,400 | New |
| Advisor Group Holdings, Inc. | 4,192 | $24.0K | 0.00% | 00.0% | Unchanged |
| Bank Julius Baer & Co. Ltd, Zurich | 2,756 | $16.0K | 0.00% | −44−1.6% | Reduced |
| Cutler Group LP | 2,700 | $15.0K | 0.00% | 00.0% | Unchanged |
| Leonteq Securities AG | 2,000 | $11.4K | 0.00% | 00.0% | Unchanged |
| Estate Counselors, LLC | 1,000 | $5.00K | 0.00% | −2,000−66.7% | Reduced |
| Wells Fargo & Company | 695 | $4.00K | 0.00% | −622−47.2% | Reduced |
| China Universal Asset Management Co., Ltd. | 780 | $4.00K | 0.00% | +780 | New |
| Zullo Investment Group, Inc. | 500 | $3.00K | 0.00% | 00.0% | Unchanged |
| Lindbrook Capital, LLC | 289 | $2.00K | 0.00% | −24−7.7% | Reduced |
| Signaturefd, LLC | 390 | $2.00K | 0.00% | +271+227.7% | Added |
| US Bancorp | 364 | $2.00K | 0.00% | +364 | New |
| Quantbot Technologies LP | 245 | $1.00K | 0.00% | −1,463−85.7% | Reduced |
| Daiwa Securities Group Inc. | 242 | $1.00K | 0.00% | 00.0% | Unchanged |
| O'Dell Group, LLC | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Costello Asset Management, INC | 100 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tyler-Stone Wealth Management | 154 | $1.00K | 0.00% | 00.0% | Unchanged |
| Quadrant Capital Group LLC | 87 | $0 | 0.00% | −43−33.1% | Reduced |
| Dark Forest Capital Management LP | 31 | $0 | 0.00% | −149−82.8% | Reduced |
| Capital Advisors, Ltd. LLC | 22 | $0 | 0.00% | +20+1,000.0% | Added |
| Ellevest, Inc. | 13 | $0 | 0.00% | −16−55.2% | Reduced |
| Quent Capital, LLC | 35 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 24 | $0 | 0.00% | +24 | New |
| Wipfli Financial Advisors LLC, | 39 | $0 | 0.00% | +39 | New |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −265,365−100.0% | Sold out |
| Privium Fund Management (UK) Ltd | 0 | $0 | 0.00% | −61,284−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −60,067−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −30,911−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −26,656−100.0% | Sold out |
| Wexford Capital LP | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −25,080−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −23,032−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −21,800−100.0% | Sold out |
| Blair William & Co | 0 | $0 | 0.00% | −14,439−100.0% | Sold out |
| Arrowstreet Capital, Limited Partnership | 0 | $0 | 0.00% | −10,878−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −10,196−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| South State Corp. | 0 | $0 | 0.00% | −565−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −502−100.0% | Sold out |
| Private Capital Group, LLC | – | – | – | – | Not filed |
| Exane Derivatives | – | – | – | – | Not filed |